BioPharma Drive: Drug Pricing
OCTOBER 6, 2023
The funding, which is part of ACT for ALS, will support expanded access studies of drugs developed by Prilenia Therapeutics, Clene Nanomedicine and Rapa Therapeutics.
Drugs.com
OCTOBER 6, 2023
THURSDAY, Oct. 5, 2023 -- A nasal spray containing a ketamine derivative appears to beat one of the standard drugs used for people with difficult-to-treat depression, a new clinical trial has found. The trial, of nearly 700 people with.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
OCTOBER 3, 2023
Researchers developed the first AI to date that can intelligently design robots from scratch by compressing billions of years of evolution into mere seconds. It's not only fast but also runs on a lightweight computer and designs wholly novel structures from scratch — without human-labeled, bias-filled datasets.
Drug Hunter
OCTOBER 5, 2023
With initial signs of efficacy and tolerability, Drug Hunter is launching into Phase III! To address your helpful feedback, we’ve rebuilt the platform from scratch to support new features and enhancements. In a few days, you’ll see the changeover to the new version go live. Show Me the Molecules! Fig. 1. The new homepage, which you can preview at v2.drughunter.com.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
BioPharma Drive: Drug Pricing
OCTOBER 2, 2023
The regulator is considering approval of what would be the first CRISPR medicine, as well as important clearances for Alnylam, Bristol Myers, Amgen and Pfizer.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Science Daily: Pharmacology News
OCTOBER 4, 2023
New research has overturned the traditional view that natural rock weathering acts as a carbon sink that removes CO2 from the atmosphere. Instead, this can also act as a large CO2 source, rivaling that of volcanoes.
Collaborative Drug
OCTOBER 3, 2023
Drug Discovery Industry Roundup with Barry Bunin — October 3, 2023 The New York Times coverage of the Nobel Prize in Physiology or Medicine being awarded.
BioPharma Drive: Drug Pricing
OCTOBER 4, 2023
The company is planning to start a Phase 3 trial of the vaccine this year, and is targeting a regulatory approval in 2025.
Drugs.com
OCTOBER 4, 2023
TUESDAY, Oct. 3, 2023 -- Federal regulators are cautioning doctors not to give probiotics to preterm infants. An infant given probiotics at an undisclosed hospital has died, U.S. Food and Drug Administration officials said in a recent warning.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Science Daily: Pharmacology News
OCTOBER 4, 2023
Winter is coming—eventually. And while the earth is warming, a new study suggests that the atmosphere is being pushed around in ways that cause long bouts of extreme winter cold or wet in some regions. The study’s authors say they have identified giant meanders in the global jet stream that bring polar air southward, locking in frigid or wet conditions concurrently over much of North America and Europe, often for weeks at a time.
Covalent Modifiers
OCTOBER 2, 2023
Haoxin Li, Tiantai Ma, Jarrett R. Remsberg, Sang Joon Won, Kristen E. DeMeester, Evert Njomen, Daisuke Ogasawara, Kevin T. Zhao, Tony P. Huang, Bingwen Lu, Gabriel M. Simon, Bruno Melillo, Stuart L. Schreiber, Jens Lykke-Andersen, David R. Liu & Benjamin F. Cravatt Nat Chem Biol, 2023 [link] Covalent chemistry represents an attractive strategy for expanding the ligandability of the proteome, and chemical proteomics has revealed numerous electrophile-reactive cysteines on diverse human protei
BioPharma Drive: Drug Pricing
OCTOBER 5, 2023
Kyowa will pay nearly $400 million to acquire Orchard, which sells the gene therapy Libmeldy in Europe but has struggled to find paths to market for other experimental treatments.
Drugs.com
OCTOBER 2, 2023
MONDAY, Oct. 2, 2023 -- This year’s Nobel Prize for physiology or medicine has been awarded to two scientists who laid the groundwork years ago for the mRNA research that made COVID-19 vaccines possible. Dr. Katalin Karikó, the 13th.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Science Daily: Pharmacology News
OCTOBER 4, 2023
Can artificial intelligence (AI) get hungry? Develop a taste for certain foods? Not yet, but a team of researchers is developing a novel electronic tongue that mimics how taste influences what we eat based on both needs and wants, providing a possible blueprint for AI that processes information more like a human being.
Covalent Modifiers
OCTOBER 3, 2023
Roman C. Sarott, Inchul You, Yen-Der Li, Sean T. Toenjes, Katherine A. Donovan, Pooreum Seo, Martha Ordonez, Woong Sub Byun, Muhammad Murtaza Hassan, Franziska Wachter, Edward T. Chouchani, Mikołaj Słabicki, Eric S. Fischer, Benjamin L. Ebert, Stephen M. Hinshaw, and Nathanael S. Gray Journal of the American Chemical Society Article ASAP DOI: 10.1021/jacs.3c06622 Targeted protein degradation relies on small molecules that induce new protein–protein interactions between targets and the cellular p
BioPharma Drive: Drug Pricing
OCTOBER 5, 2023
The company says Syfovre prescriptions accelerated again in August after a rocky summer of side effect probes.
Drugs.com
SEPTEMBER 30, 2023
FRIDAY, Sept. 29, 2023 -- Faced with growing reports of inaccurate clinical lab tests, the U.S. Food and Drug Administration on Friday announced that it will for the first time regulate these vital diagnostic tools. Many Americans might have.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Science Daily: Pharmacology News
OCTOBER 4, 2023
Researchers have produced an engineered tissue representing a simplified cerebral cortex by 3D printing human stem cells. When implanted into mouse brain slices, the structures became integrated with the host tissue. The technique may ultimately be developed into tailored repairs to treat brain injuries.
Broad Institute
OCTOBER 3, 2023
Broad Clinical Labs established to expand clinical services By Leah Eisenstadt October 3, 2023 Breadcrumb Home Broad Clinical Labs established to expand clinical services Formerly the Clinical Research Sequencing Platform, the cutting-edge laboratory at the Broad Institute is poised to further accelerate clinical genomics. By Broad Communications October 3, 2023 The Broad's Clinical Research Sequencing Platform is now Broad Clinical Labs.
BioPharma Drive: Drug Pricing
OCTOBER 3, 2023
The longtime partners believe that, by combining their technologies, they can create “in vivo” genetic medicines for nervous system and muscular disorders.
Drugs.com
SEPTEMBER 30, 2023
FRIDAY, Sept. 29, 2023 – When pregnant women get a COVID vaccine, it helps protect their newborns from the virus, a new government study shows. "These findings indicate that maternal vaccination during pregnancy could help prevent.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Science Daily: Pharmacology News
OCTOBER 5, 2023
Imagine a life form that doesn't resemble any of the organisms found on the tree of life. One that has its own unique control system, and that a doctor would want to send into your body. It sounds like a science fiction movie, but according to nanoscientists, it can—and should—happen in the future.
Broad Institute
OCTOBER 4, 2023
Cancer immunotherapy candidate provokes powerful dual response in cancer and immune cells By Allessandra DiCorato October 4, 2023 Breadcrumb Home Cancer immunotherapy candidate provokes powerful dual response in cancer and immune cells The small molecule, now in clinical trials, increases activity of immune cells and sensitivity of tumors to immune attack.
BioPharma Drive: Drug Pricing
OCTOBER 3, 2023
The deal will hand Lilly a pipeline of experimental radioligand therapies, including a potential rival to Novartis’ Pluvicto, as well as a valuable manufacturing plant.
Drugs.com
OCTOBER 6, 2023
THURSDAY, Oct. 5, 2023 -- Wallet-friendly cards showing proof of COVID vaccinations served a purpose early in the pandemic, but they’re on their way out. The U.S.
Science Daily: Pharmacology News
OCTOBER 5, 2023
Researchers have identified a 'guard mechanism' for a protein which attacks microbes in infected cells, opening the possibility of new treatments for Toxoplasma, Chlamydia, Tuberculosis and even cancer.
Expert insights. Personalized for you.
305 
Let's personalize your content